Schedule 13D ownership disclosure
ANI Pharmaceuticals Inc
Security class unavailable · CUSIP: 00182C103
Event date: 2021-11-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.9600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-029325
- Form type
- SC 13D
- Filer
- ANI PHARMACEUTICALS INC
- CIK
- CIK 1023024
- Filed
- Mar 02, 2022
- Reporting period
- Nov 19, 2021
- Description
- Schedule 13D beneficial ownership